Toronto Dominion Bank lessened its position in shares of SPDR S&P Biotech (NYSEARCA:XBI) by 55.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 3,150 shares of the exchange traded fund’s stock after selling 3,900 shares during the quarter. Toronto Dominion Bank’s holdings in SPDR S&P Biotech were worth $277,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech in the 1st quarter valued at $118,628,000. Alliancebernstein L.P. bought a new position in SPDR S&P Biotech during the 4th quarter valued at $75,489,000. State of Tennessee Treasury Department bought a new position in SPDR S&P Biotech during the 4th quarter valued at $12,018,000. Whittier Trust Co. lifted its stake in SPDR S&P Biotech by 6,985.1% during the 1st quarter. Whittier Trust Co. now owns 136,389 shares of the exchange traded fund’s stock valued at $11,964,000 after acquiring an additional 134,464 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its stake in SPDR S&P Biotech by 4.3% during the 4th quarter. Wells Fargo & Company MN now owns 1,511,948 shares of the exchange traded fund’s stock valued at $128,318,000 after acquiring an additional 62,486 shares in the last quarter.
Shares of SPDR S&P Biotech opened at $99.08 on Friday, Marketbeat reports. SPDR S&P Biotech has a 1-year low of $74.25 and a 1-year high of $101.55.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 20th. Shareholders of record on Monday, June 18th were paid a dividend of $0.0585 per share. This represents a $0.23 annualized dividend and a yield of 0.24%. The ex-dividend date of this dividend was Friday, June 15th.
About SPDR S&P Biotech
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.